header

2017

2017

1.      Wucherer D, Thyrian JR, Eichler T, Hertel J, Kilimann I, Richter S, Michalowsky B, Zwingmann I, Dreier-Wolfgramm A, Ritter CA, Teipel SJ, Hoffmann W. Drug-related problems in community-dwelling primary care patients screened positive for dementia. Int. Psychogeriatr, 2017, epub ahead of print (IF 0,68)

 

2.      Thyrian JR, Hertel J, Wucherer D, Eichler T, Michalowsky B, Dreier-Wolfgramm A, Zwingmann I, Kilimann I, Teipel SJ, Hoffmann W. Effectiveness and Safety of Dementia Care Management in Primary Care: A Randomized Clinical Trial. JAMA Psychiatry, 2017, epub ahead of print (IF 15,3)

 

3.      Lista S, Toschi N. Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Dos Santos AM, Epelbaum S, Lamari F, Dubois B, Nistico R, Floris R, Garaci F, Hampel H; Alzheimer Precision Medicine Initiative (APMI). Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study. J Alzheimers Dis, 2017, epub ahead of print (IF 3,92 )

 

4.      Dyrba M, Grothe MJ, Mohammadi A, Binder H, Kirste T, Teipel SJ; Alzheimer’s Disease Neuroimaging Initiative. Comparison of Different Hypotheses Regarding the Spread of Alzheimer’s Disease Using Markov Random Fields and Multimodal Imaging. J Alzheimers Dis, 2017, epub ahead of print (IF 3,92)

 

5.      Kuhla A, Rühlmann C, Lindner T, Polei S, Hadlich S, Krause BJ, Vollmar B, Teipel SJ. APPswe/PS1dE9 mice with cortical amyloid pathology show a reduced NAA/Cr ratio without apparent brain atrophy: A MRS and MRI study. Neuroimaging Clin, 2017, eCollection (IF 4,35)

 

6.      Teipel SJ, Cavedo E, Weschke S, Grothe MJ, Rojkova K, Fontaine G, Dauphinot L, Gonzalez-Escamilla G, Potier MC, Bertin H, Habert MO, Dubois B, Hampel H; INSIGHT-preAd study group. Cortical amyloid accumulation is associated with alterations of structural integrity in older people with subjective memory complaints. Neurobiol. Aging, 2017, 57:143-152 (IF 5,12)

 

7.      Frisoni G, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet JF, Garibotto V, Giannakopoulos P, Gietl A, Hannson O, Herholz K, Jack Jr C R, Nobili F, Nordberg A, Snyder HM, Kate MT, Varrone A, Albanese E, Becker S, Bossuyt P, Carrillo MC, Cerami C, Dubois B, Gallo V, Giacobini E, Gold G, Hurst S, Lönneborg A, Lovblad KO, Mattson N, Molinuevo JL, Monsch AU, Mosimann U, Padovani A, Pico A, Porteri C, Ratib O, Saint-Aubert L, Scerri C, Scheltens P, Schott JM, Sonni I, Teipel SJ, Vineis P, Visser PJ, Yasui Y, Winblad B. Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers. Lancet Neurol, 2017, 16:661-76 (IF 26,28)

 

8.      Cavedo E, Lista S, Rojkova K, Andrea Chiesa P, Houot M, Brueggen K, Blautzik J, Bokde ALW, Dubois B, Barkhof F, Pouwels PJW, Teipel SJ, Hampel H; Alzheimer Precision Medicine Initiative (APMI). Disrupted white matter structural networks in healthy older adults APOE 4 carriers – An International Multicenter DTI Study. Neuroscience, 2017, epub ahead of print (IF 3,23)

 

9.      Guo S, Lai C, Wu C, Cen G; Alzheimer’s Disease Neuroimaging Initiative. Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images. Front Aging Neurosci, 2017, 18;9:146 (IF4,72)

 

10.    Lista S, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Dos Santos AM, Epelbaum S, Lamari F, Dubois B, Floris R, Garaci F, Hampel H; Alzheimer Precision Medicine Initiative (APM). Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer’s disease. Neurochem Int, 2017, epub ahead of print (IF3,39)

 

11.    Gollan JK, Dong H, Bruno D, Nierenberg J, Nobrega JN, Grothe MJ, Pollock BG, Marmar CR, Teipel SJ, Csernansky JG, Pomara N. Basal forebrain mediated increase in brain CRF is associated with increased cholinergic tone and depression. Psychiatry Res, 2017, 264:76-81 (IF2,47)

 

12.    Teipel SJ, Heine C, Hein A, Krüger F, Kutschke A, Kernebeck S, Halek M, Bader S, Kirste T. Multidimensional assessment of challenging behaviors in advanced stages of dementia in nursing homes – The insideDEM framework. Alzheimers Dement, Diagnosis Assessment & Monitoring, 2017, 4;8:36-44 (IF2,50)

 

13.    Kilimann I, Thyrian JR, Hoffmann W, Teipel SJ. Translation of imaging biomarkers from clinical research to healthcare. Z Gerontol. Geriatr, 2017, 50(Suppl 2):84-88 (IF 0,77)

 

14.    Ochmann S, Dyrba M, Grothe MJ, Kasper E, Webel S, Hauenstein K, Teipel SJ. Does functional Connectivity Provide a Marker for Cognitive Rehabiliation Effects in Alzheimer’s disease? An Interventional Study. J Alzheimers Dis, 2017, 57(4):1303-1313 (IF 3,92)

 

15.    Brüggen K, Kasper E, Ochmann S, Pfaff H, Webel S, Schneider W, Teipel SJ. Cognitive Rehabilitation in Alzheimer’s Disease: A Controlled Intervention Trial. J. Alzheimer’s Dis, 2017, 57(4):1315-1324 (IF 3,92)

 

16.    Liu Q, Zhu Z, Teipel SJ, Yang J, Xing Y, Tang Y, Jia J. White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia, Front Aging Neurosci, 2017, 9:47 (IF 4,35)

 

17.    Baldacci F, Toschi N, Lista S, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Dos Santos AM, Epelbaum S, Lamari F, Dubois B, Floris R, Garaci F, Bonuccelli U, Hampel H. Two-Level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer’s disease., Alzheimers Dement, 2017, e-pub ahead of print (IF 11,62)

 

18.    Teipel SJ, Wohlert A, Metzger CD, Grimmer T, Sorg C, Ewers M, Meisenzahl E, Klöppel S, Borchardt V, Grothe MJ, Walter M, Dyrba M: Multicenter stability of resting state fMRI in the detection of Alzheimer’s disease and amnestic MCI. NeuroImage: Clinical, 2017, 14:183-194 (IF 3,86) 

 

19.    Teipel SJ, Grothe MJ, Metzger CD, Grimmer T, Sorg C, Ewers M, Franzmeier N, Meisenzahl E, Klöppel S, Borchardt V, Walter M, Dyrba M (2017): Robust Detection of Impaired Resting State Functional Connectivity Networks in Alzheimer's Disease Using Elastic Net Regularized Regression. Front. Aging Neurosci., 2017, 8:318. doi: 10.3389/fnagi.2016.00318 (IF 4,35)

 

20.    Teipel SJ, Keller F, Thyrian JR, Strohmaier U, Altiner A, Hoffmann W, Kilimann I. Hippocampus and basal forebrain volumetry for dementia and mild cognitive impairment diagnosis: Could it be useful in primary care? J Alzheimers Dis, 2017, 55(4):1379-1394 (IF 3,92)

 

21.    Wucherer D, Eichler T, Hertel J, Kilimann I, Richter S, Michalowsky B, Thyrian JR, Teipel SJ, Hoffmann W. Potentially inappropriate medication in community-dwelling primary care patients who were screened positive for dementia. J Alzheimers Dis, 2017, 55(2):691-701 (IF 3,27)

 

22.    Brueggen K, Grothe MJ, Dyrba M, Fellgiebel A, Fischer F, Filippi M, Agosta F, Nestor P, Meisenzahl E, Blautzik J, Frölich L, Hausner L, Bokde AL, Frisoni G, Pievani M, Klöppel S, Prvulovic D, Barkhof F, Pouwels PJ, Schröder J, Hampel H, Hauenstein K, Teipel SJ. The European DTI Study on Dementia – a multicenter DTI and MRI study on AD and MCI. Neuroimage, 2017, 144(Pt B):305-308 (IF 5,46)

 

23.    Kilimann I, Hausner L, Fellgiebel A, Filippi M, Würdemann TJ, Heinsen H, Teipel SJ. Parallel Atrophy of Cortex and Basal Forebrain Cholinergic System in Mild Cognitive Impairment, Cereb Cortex, 2017, 27(3): 1841-1848 (IF 8,23)

 

24.    Franzmeier N, Buerger K, Teipel SJ, Stern Y, Dichgans M, Ewers M; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Cognitive reserve moderates the association between functional network anti-correlations and memory in MCI. Neurobiol Aging, 2017, 50:152-162 (IF 5,15)

 

25.    Gonzalez-Escamilla G, Lange C, Teipel SJ, Buchert R, Grothe MJ, for the Alzheimer’s Disease Neuroimaging Initiative. PETPVE12: an SPM toolbox for partial volume effects correction in brain PET – application to amyloid imaging with AV45-PET. Neuroimage, 2017, 147:669-677 (IF 5,46)